Risperdal Lawsuit News: Arkansas Supreme Court Overturns $1.2 Billion Risperdal Verdict, Bernstein L

The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly experienced gynecomastia (male breast development) due to Risperdal. New York, NY (PRWEB) March 21, 2014 Johnson & Johnson has been successful in its bid to have a $1.2 billion verdict rendered in an Arkansas Risperdal lawsuit (http://www.risperdallawsuitcenter.com/) overturned, Bernstein Liebhard LLP reports. According to a decision rendered yesterday, the high court ruled that the state had relied on the wrong law when it originally filed suit against Johnson & Johnson and its Janssen Pharmaceuti
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations